Eureka Alert

A drug to treat Alzheimer's disease is increasingly proving elusive, despite billions of dollars spent on research and development. Johnson & Johnson (NYSE: JNJ)'s Janssen unit; Merck & Co., Inc. (NYSE: MRK); and Eli Lilly And Co (NYSE: LLY) in collaboration with AstraZeneca...